
To determine the prevalence of zzso and the use of zzso in terminal zzso 

zzso 

Hospice zzso zzso the zzso 

Of patients who were admitted for terminal care between 1 January 1995 and 15 July 1996 the zzso data were recorded about presence of zzso and use of zzso notably zzso and zzso 

The study population zzso zzso zzso consisted of 65 male and 56 female zzso 95 patients zzso suffered from zzso The median survival time was 18 days zzso from zzso zzso 58 zzso of the patients were zzso at the time of admission and 62 zzso used zzso The zzso users were more often zzso zzso versus zzso p zzso zzso 35 out of 62 zzso zzso users were given zzso The zzso users, however, were more often zzso zzso versus zzso p zzso zzso Neither in users nor in zzso of zzso did zzso have any effect on presence of zzso Of the zzso users 37 zzso were given zzso in a fixed zzso 

Present zzso policy in terminal patients is zzso zzso with fixed zzso doses is not effective as a zzso in either users or zzso of zzso 

